The Current Status of Helicobacter pylori Vaccines: A Review

@article{Kabir2007TheCS,
  title={The Current Status of Helicobacter pylori Vaccines: A Review},
  author={Shahjahan Kabir},
  journal={Helicobacter},
  year={2007},
  volume={12}
}
  • S. Kabir
  • Published 2007
  • Biology, Medicine
  • Helicobacter
Helicobacter pylori, a Gram‐negative flagellate bacterium that infects the stomach of more than half of the global population, is regarded as the leading cause of chronic gastritis, peptic ulcer disease, and even gastric adenocarcinoma in some individuals. Although the bacterium induces strong humoral and cellular immune responses, it can persist in the host for decades. It has several virulence factors, some of them having vaccine potential as judged by immunoproteomic analysis. A few… Expand
Helicobacter pylori: A Brief History of a Still Lacking Vaccine
TLDR
Efficacy trials have given unsatisfactory results, so far, with bacterial colonization remaining unaffected by vaccination; however, a vaccine able to counteract H. pylori-induced diseases, such as gastric cancer, even without providing sterilizing immunity, could be considered valuable. Expand
Helicobacter pylori Pathogenesis and Vaccines
TLDR
Observations made in both animals and humans have provided evidence that the natural response to H. pylori infection is of Th1 type; nevertheless, this response, although strong, is rarely able to clear the infection. Expand
Helicobacter pylori vaccination: is there a path to protection?
TLDR
H. pylori can be eradicated by antibiotic treatment in combination with a proton-pump inhibitor, but efficacy is decreasing, underlining the need for novel therapeutics. Expand
Heat shock protein A of Helicobacter pylori: a promising vaccine candidate
TLDR
The properties of heat shock protein A (HspA), such as its structural conservation and good immunogenicity, are described as one of the candidate antigens with most potential and its inclusion in an H. pylori vaccine is described. Expand
The study of H. pylori putative candidate factors for single- and multi-component vaccine development
TLDR
More work should be done on epitope mapping, analysis of molecular structure, and determination of the antigen determinant region as well due to design a vaccine, preferably a multi-component vaccine to elicit specific CD4 T-cell responses that are required for H. pylori vaccine efficacy. Expand
Exploring alternative treatments for Helicobacter pylori infection.
TLDR
This review summarises the most relevant recent studies on vaccine development and new treatments using natural resources such as plants, probiotics and nutraceuticals and proposes novel alternatives based on microorganisms, peptides, polysaccharides, and intragastric violet light irradiation. Expand
Inhibition of H. pylori colonization and prevention of gastritis in murine model
TLDR
The results support the idea that UreC andUreCc specific antibodies contribute to protection against H. pylori infections and confirm establishment of immunity. Expand
Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice.
TLDR
It has been demonstrated that this novel bacterial ghost based DNA vaccine could be used as a promising vaccine candidate for the control of H. pylori infection. Expand
Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.
TLDR
The development of measles virus (MV) vaccine strain encoding the NAP antigen is presented and it is demonstrated that MV is an excellent vector platform for expression of bacterial antigens and development of vaccines for H. pylori immunoprophylaxis in humans. Expand
Helicobacter pylori: immunoproteomics related to different pathologies
TLDR
This review describes how several research groups used H. pylori proteomics combined with western blotting analysis, using sera from patients affected with different H. Pylori-related pathologies, to investigate potential associations between host immune response and clinical outcomes of H.pylori infection, resulting in the rapid identification of novel, highly immunoreactive antigens. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 185 REFERENCES
Immunology of Helicobacter pylori Infection
TLDR
The understanding of the mechanisms leading to the Helicobacter persistence or the vaccine-induced eradication of Helicobacteria in animal models will help to define optimal immunization strategies for future anti-Helicobacter vaccination clinical trials. Expand
The design of vaccines against Helicobacter pylori and their development.
TLDR
It appears, however, that after immunization, the antigen-specific response is predominantly polarized toward a Th2-type response, with production of cytokines that can inhibit the activation of Th1 cells and of macrophages, and the production of proinflammatory cytokines. Expand
Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy
ABSTRACT Helicobacter pylori is a gram-negative bacterium that colonizes the human gastric mucosa causing gastritis and peptic ulcer and increasing the risk of gastric cancer. The efficacy of currentExpand
Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?
TLDR
Formulation of equivalent safe vaccines of H. pylori will make possible the immunisation of children in countries such as China, Japan and Columbia and so prevent the establishment of long term inflammation and thus significantly reduce the incidence of gastric cancer in those societies. Expand
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
TLDR
It is reported that an otherwise chronic H. pylori infection in mice can be successfully eradicated by intragastric vaccination with H.pylori antigens such as recombinant VacA and CagA, and it is shown that therapeutic vaccination confers efficacious protection against reinfection. Expand
Mucosal Immunization with a Urease B DNA Vaccine Induces Innate and Cellular Immune Responses Against Helicobacter pylori
TLDR
This work has shown that the antigenic potential of its urease enzyme, a critical virulence factor required for colonization of the gastric mucosa, has been demonstrated in animal and human studies and is an important but controversial issue in H. pylori vaccine studies. Expand
Helicobacter pylori.
TLDR
Advances in the detection of the presence of the organism and methods of differentiating among types of H. pylori are highlighted, and a background for appropriate chemotherapy of the infection is provided. Expand
Helicobacter pylori-Specific Antibodies Impair the Development of Gastritis, Facilitate Bacterial Colonization, and Counteract Resistance against Infection 1
TLDR
It is reported that Abs not only are dispensable for protection, but they are detrimental to elimination of the bacteria and appear to impair gastric inflammatory responses. Expand
Safety and Immunogenicity of Oral Inactivated Whole-CellHelicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection
TLDR
It is suggested that it is possible to stimulate mucosal and systemic immune responses in humans to H. pylori antigens by using an HWC vaccine. Expand
Oral immunization against Helicobacter pylori
TLDR
Prevention of initial colonization of the gastrointestinal tract may be a viable alternative for abrogation of H. pylori-associated gastroduodenal disease and oral immunization with killed H.pylori may be feasible approach to protect hosts from this infection and the accompanying gastroduodermal disease. Expand
...
1
2
3
4
5
...